As of December 15, 2025, China Pharma Holdings Inc (CPHI) reports a Gross Margin of -43.84%.
Gross Margin indicates the portion of sales revenue remaining after covering production costs, highlighting operational efficiency.
Historical Trend of China Pharma Holdings Inc's Gross Margin
Over recent years, China Pharma Holdings Inc's Gross Margin has shown significant volatility. The table below summarizes the historical values:
| Date | Gross Margin |
|---|---|
| 2024-12-31 | -43.84% |
| 2023-12-31 | -4.01% |
| 2022-12-31 | -6.10% |
| 2021-12-31 | 3.62% |
| 2020-12-31 | 17.96% |
This slight downward trend highlights how China Pharma Holdings Inc manages its operational efficiency and pricing power over time.
Comparing China Pharma Holdings Inc's Gross Margin to Peers
To better understand China Pharma Holdings Inc's position, it's useful to compare its Gross Margin against industry peers. Below are selected comparisons:
| Company | Gross Margin |
|---|---|
| China Pharma Holdings Inc (CPHI) | -43.84% |
| Tree of Knowledge International Corp (TOKI.CN) | 2992.87% |
| Nutritional High International Inc (EAT.CN) | 2258.97% |
| MJ Holdings Inc (MJNE) | 100.00% |
| Titan Pharmaceuticals Inc (TTNP) | 100.00% |
| MPX International Corp (MPXI.CN) | 65.40% |
Compared to its competitors, China Pharma Holdings Inc's Gross Margin is lower than all peers, suggesting potential challenges in production costs or pricing strategy.